期刊文献+

阿奇霉素导致严重肝功能损害合并窦性心动过缓1例

One Case of Severe Liver Function Damdge with Sinus Brabycardia Caused by Azithromycin
下载PDF
导出
摘要 1例门诊诊断为支气管炎的患者选用阿奇霉素静滴2天后出现严重肝功能损害及窦性心动过缓,心率最低达到38次/分,不良反应涉及消化和心血管两大系统,经积极治疗后得到顺利恢复,无后遗症。通过此次事件,临床治疗中,应了解和关注阿奇霉素的不良反应,在选择使用该药前应对患者综合情况给予谨慎评估,在治疗过中及治疗后均应该加强随访。 One patient who had been diagnosed bronchitis used azithromycin by intravenous drip for two days ,server liver function damage with sinus brabycardia occured. The slowest heart rate comed to 38 times per minute. The adverse reaction involved two major systems of digestion and cardiovascular. After accepted active treatment, the patient recovered her health and no sequelae. About this incident we should be more understanding and pay attention to adverse reaction of azithromycin in clinical treatment. Before choosing to use this drug we should be more cautious and strengthened folowed-up in and after the treatment.
作者 王云
出处 《中国卫生标准管理》 2015年第19期95-96,共2页 China Health Standard Management
关键词 阿奇霉素 不良发应 肝功能损害 窦性心动过缓 Azithromycin Adverse reaction Liver function damage Sinus brabycardia
  • 相关文献

参考文献5

二级参考文献25

  • 1邓万俊.抗菌药物的心脏毒性[J].中国医院药学杂志,2005,25(3):263-265. 被引量:9
  • 2张庆友,卢良军,邹丹.阿奇霉素致可逆性室上性心动过速1例[J].药物流行病学杂志,2005,14(5):305-305. 被引量:15
  • 3陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:3465. 被引量:845
  • 4FDA. FDA Drug Safety Communication : azithromycin ( Zithromax or Zmax) and the risk of potentially fatal heart rhythms [ EB/ OL]. ( 2013-03-12 ) [ 2013-04-19 ]. http://www, fda. gov/ drugs/drugsafety/ucm341822, htm. 被引量:1
  • 5Ray WA, Murray KT, Hall K, et al. Azithromyein and the risk of cardiovascular death. N Engl J Med, 2012, 366(20):1881- 1890. 被引量:1
  • 6FDA. FDA Statement regarding azithmmycin (Zithromax) and the risk of cardiovascular death [ EB/OL]. (2012-05-17) [ 2013-04- 19 ]. http ://www. fda. gov/Drugs/DrugSafety/ucm304372, htm. 被引量:1
  • 7FDA. FDA Drag Safety Podcast: azithmmycin (Zithmmax or Zmax) and the risk of potentially fatal heart rhythms I EB/OLI- (2013-03-14) [2013-04-19]. http://wwv, fda. gov/Drugs/Drug- Safety/DrugSafetyPodcasts/ucm343678. htm. 被引量:1
  • 8Ray WA, Murray KT, Hall K, et al. Azithromycin andthe risk of cardiovascular death[J]. N Engl J Med, 2012,366(20): 1881-1890. 被引量:1
  • 9Vincenzo Russo, Gianfranco Puzio, Nicola Siniscalchi.Azithromycin-induced QT prolongation in elderlypatient[J]. ACTA BIOMED, 2006,77: 30-32. 被引量:1
  • 10HUANG BH,WU CH , HSIA CP, et al. Azithromycin-induced torsade de pointes[J]. Pacing Clin Electrophysiol,2007, 30(12): 1579-1582. 被引量:1

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部